Who
Jonathan Siegal
Principal Accounting Officer
Company insider
Files Form 4 as: Principal Accounting Officer, Vericel.
In numbers
- Trades disclosed
- 113
- Buys
- 0
- Sells
- 14
- Bought
- $0
- Sold
- $1.7M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 18 Feb 2022
- Last trade
- 30 Jul 2026
- Last filed
- 31 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 30 Jul 2026filed 31 Jul 2026 | VCEL VericelBiotechnology | SEC FORM 4 Code M | $52K1,500 at $34.90 | filing |
| 30 Jul 2026filed 31 Jul 2026 | VCEL VericelBiotechnology | SEC FORM 4 Sold | $73K1,500 at $48.90 | filing |
| 30 Jul 2026filed 31 Jul 2026 | VCEL VericelBiotechnology | SEC FORM 4 Code M | $75K2,500 at $29.82 | filing |
| 30 Jul 2026filed 31 Jul 2026 | VCEL Vericeloption or derivative · Biotechnology | SEC FORM 4 Code M | —1,500 at $0.00 | filing |
| 30 Jul 2026filed 31 Jul 2026 | VCEL Vericeloption or derivative · Biotechnology | SEC FORM 4 Code M | —2,500 at $0.00 | filing |
| 30 Jul 2026filed 31 Jul 2026 | VCEL Vericeloption or derivative · Biotechnology | SEC FORM 4 Code M | —500 at $0.00 | filing |
| 30 Jul 2026filed 31 Jul 2026 | VCEL VericelBiotechnology | SEC FORM 4 Sold | $122K2,500 at $48.90 | filing |
| 30 Jul 2026filed 31 Jul 2026 | VCEL VericelBiotechnology | SEC FORM 4 Code M | $15K500 at $29.82 | filing |
| 30 Jul 2026filed 31 Jul 2026 | VCEL VericelBiotechnology | SEC FORM 4 Sold | $24K500 at $48.90 | filing |
| 30 Jul 2026filed 31 Jul 2026 | VCEL Vericeloption or derivative · Biotechnology | SEC FORM 4 Code M | —1,500 at $0.00 | filing |
| 30 Jul 2026filed 31 Jul 2026 | VCEL Vericeloption or derivative · Biotechnology | SEC FORM 4 Code M | —2,500 at $0.00 | filing |
| 30 Jul 2026filed 31 Jul 2026 | VCEL Vericeloption or derivative · Biotechnology | SEC FORM 4 Code M | —500 at $0.00 | filing |
| 30 Jul 2026filed 31 Jul 2026 | VCEL VericelBiotechnology | SEC FORM 4 Code M | $52K1,500 at $34.90 | filing |
| 30 Jul 2026filed 31 Jul 2026 | VCEL VericelBiotechnology | SEC FORM 4 Sold | $73K1,500 at $48.90 | filing |
| 30 Jul 2026filed 31 Jul 2026 | VCEL VericelBiotechnology | SEC FORM 4 Code M | $75K2,500 at $29.82 | filing |
| 30 Jul 2026filed 31 Jul 2026 | VCEL VericelBiotechnology | SEC FORM 4 Sold | $122K2,500 at $48.90 | filing |
| 30 Jul 2026filed 31 Jul 2026 | VCEL VericelBiotechnology | SEC FORM 4 Code M | $15K500 at $29.82 | filing |
| 30 Jul 2026filed 31 Jul 2026 | VCEL VericelBiotechnology | SEC FORM 4 Sold | $24K500 at $48.90 | filing |
| 26 Jun 2026filed 30 Jun 2026 | VCEL VericelBiotechnology | SEC FORM 4 Sold | $10K232 at $44.90 | filing |
| 26 Jun 2026filed 30 Jun 2026 | VCEL VericelBiotechnology | SEC FORM 4 Code M | $75K2,500 at $29.82 | filing |
News
No headline names them, or the companies they trade most, lately.